Advanced Turinabol Research Compound
TURINABOLOS Pharmacom is a sophisticated anabolic-androgenic steroid (AAS) preparation designed for comprehensive laboratory investigations. This synthetic derivative of Dianabol features a unique 4-chloro-17α-methyl-17β-hydroxyandrost-1,4-dien-3-one molecular structure, offering researchers a distinctive tool for examining modified testosterone pathways and protein synthesis mechanisms. Manufactured by Pharmacom Labs under strict pharmaceutical protocols, each tablet contains precise compound concentrations suitable for controlled experimental conditions. Research laboratories at Stroid UK Shop utilise this compound to investigate anabolic signalling cascades and cellular response patterns in controlled environments.
Research Applications and Mechanisms
Laboratory studies examine TURINABOLOS’s unique pharmacological profile, particularly its modified androgen receptor binding characteristics and reduced aromatisation potential compared to traditional testosterone derivatives. Research teams investigate the compound’s tissue-selective anabolic activity, examining how the 4-chloro modification influences cellular uptake and protein synthesis pathways. Studies focus on androgenic receptor modulation, nitrogen retention mechanisms, and glycogenesis processes in various tissue models. Comparative analyses with compounds available in our Turinabol oral steroids category enable comprehensive research into structural-activity relationships and bioavailability profiles across different anabolic steroid formulations.
Specifications and Research Data
| Parameter | Value |
|---|---|
| Chemical Name | 4-chloro-17α-methyl-17β-hydroxyandrost-1,4-dien-3-one |
| CAS Number | 2446-23-3 |
| Molecular Formula | C₂₀H₂₇ClO₂ |
| Molecular Weight | 334.88 g/mol |
| Form | Oral tablets |
| Storage | Room temperature, dry environment |
| Solubility | Ethanol, DMSO |
Research protocols require precise environmental controls and proper storage conditions to maintain compound integrity. Cross-referencing with SARMs and peptides enables comparative mechanistic studies between different anabolic pathways and receptor-mediated cellular responses.
Laboratory Compliance Statement
TURINABOLOS Pharmacom is manufactured exclusively for laboratory research purposes and in-vitro applications. This product is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, safety procedures, and regulatory compliance when conducting studies with this compound. All research should be performed by qualified personnel in appropriately equipped facilities following institutional guidelines for anabolic steroid research.
